RxDoctor Payments Data

Spencer Hawkins, MD

MOHS-Micrographic Surgery · Marietta, GANPI 1831621721

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 26.5% of the total.

$6,221in general payments, 2019–2025

Across 295 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$908
  • LEO Pharma Inc.$584
  • Regeneron Healthcare Solutions, Inc.$507
  • Pfizer$387
  • Sanofi$376
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$6,221100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,221 in reported general payments places this provider in the 65th percentile of 40 mohs-micrographic surgery providers in Georgia.

See all mohs-micrographic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$469,811
Medicare patients
494
Services billed
1,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate99$3,481
Fluorouracil17$1,185
Ketoconazole55$950
Cephalexin37$452
Dutasteride19$426
Minoxidil31$345
Triamcinolone Acetonide33$297
Mupirocin25$162
ValacyclovirValacyclovir Hcl12$104

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →